Lipid formulation of apoptosis promoter

Details for Australian Patent Application No. 2010242925 (hide)

Owner Abbott Laboratories

Inventors David, Paul; Fickes, Michael; Fischer, Cristina; Haight, Anthony R.; Heemstra, Katherine; Marsh, Kennan; Mayer, Peter; Rubin, Vitaly; Sanzgiri, Yeshwant; Schmitt, Eric; Tong, Ping; Zhou, Deliang

Agent Spruson & Ferguson

Pub. Number AU-A-2010242925

PCT Pub. Number WO2010/127192

Priority 61/174,245 30.04.09 US

Filing date 30 April 2010

Wipo publication date 4 November 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/5377 (2006.01)

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/127192 Priority application(s): WO2010/127192

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010242926-Stabilized lipid formulation of apoptosis promoter

2010242923-Salt of ABT-263 and solid-state forms thereof